Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07591740 · ClinicalTrials.gov registry record
Xpert Hemorrhagic Fever on Edge X in Trained and Untrained Users
A clinical trial, sponsored by Cepheid.
- Completed
- Registry status
- 725
- Enrollment target
NCT07591740 is a clinical trial that has completed, run by Cepheid. The registered enrollment target is 725 participants.
The verdict
NCT07591740 has completed, sponsored by Cepheid.
- COMPLETED
- Registry status
- 725 participants
- Enrollment target
Study Summary
A multi-site observation study that was conducted in the United States at 3 CLIA Waived sites with Untrained Users testing on Xpert Hemorrhagic fever tests on Edge X instruments
Interventions
- DIAGNOSTIC_TEST Xpert Hemorrhagic Fever test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 725 participants |
| Start Date | 2024-10-21 |
| Est. Completion | 2026-03-13 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07591740
The ClinicalTrials.gov registry entry for NCT07591740 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 725 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cepheid, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Xpert Hemorrhagic Fever test is the first listed.
NCT07591740 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07591740 about?
NCT07591740 is a clinical study titled "Xpert Hemorrhagic Fever on Edge X in Trained and Untrained Users". A multi-site observation study that was conducted in the United States at 3 CLIA Waived sites with Untrained Users testing on Xpert Hemorrhagic fever tests on Edge X instruments
What is the current status of trial NCT07591740?
This trial is currently completed. The enrollment target is 725 participants. The study started on 2024-10-21. Estimated completion is 2026-03-13.
What interventions are being tested in trial NCT07591740?
The interventions under investigation include: Xpert Hemorrhagic Fever test (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT07591740?
This trial is sponsored by Cepheid, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.